Key result
Middle cardiac vein leads cut defibrillation thresholds ~56% compared to conventional RV leads.
Why the study?
The efficacy of a novel defibrillation lead system placed in the middle cardiac vein compared to a conventional non-thoracotomy lead system was unknown.
Does a novel lead system placed in the middle cardiac vein reduce defibrillation energy requirements compared to a conventional non-thoracotomy lead system in a pig model?
RCT (n=8)
randomised
Does a novel lead system placed in the middle cardiac vein reduce defibrillation energy requirements compared to a conventional non-thoracotomy lead system in a pig model?
Placement of defibrillation electrodes within the middle cardiac vein significantly reduces defibrillation energy requirements compared to conventional right ventricular leads in a porcine model.
Answers are grounded in this paper and cite their sources.
Novel middle cardiac vein defibrillation leads feasible in pigs; leaves open human efficacy and safety.
OBJECTIVE: To compare the defibrillation efficacy of a novel lead system placed in the middle cardiac vein with a conventional non-thoracotomy lead system. METHODS: In eight pigs (weighing 35-71 kg), an electrode was advanced transvenously to the right ventricular apex (RV), with the proximal electrode in the superior caval vein (SCV). Middle cardiac vein (MCV) angiography was used to delineate the anatomy before a three electrode system (length 2 x 25 mm + 1 x 50 mm) was positioned in the vein. An active housing (AH) electrode was implanted in the left pectoral region. Ventricular fibrillation was induced and biphasic shocks were delivered by an external defibrillator. The defibrillation threshold was measured and the electrode configurations randomised to: RV-->AH, RV+MCV-->AH, MCV-->AH, and RV-->SCV+AH. RESULTS: For these configurations, mean (SD) defibrillation thresholds were 27.3 (9.6) J, 11.9 (2.9) J, 15.2 (4.3) J, and 21.8 (9.3) J, respectively. Both electrode configurations incorporating the MCV had defibrillation thresholds that were significantly less than those observed with the RV-->AH (p < 0.001) and RV-->SCV+AH (p < 0.05) configurations. Necropsy dissection showed that the MCV drained into the coronary sinus at a location close to its orifice (mean distance = 2.7 (2.2) mm). The MCV bifurcated into two main branches that drained the right and left ventricles, the left branch being the dominant vessel in the majority (6/7) of cases. CONCLUSIONS: Placement of specialised defibrillation electrodes within the middle cardiac vein provides more effective defibrillation than a conventional tight ventricular lead.
No takes yet. Share an insight, caveat, or question.
Paul Richard Roberts (2000) conducted an RCT in Ventricular fibrillation (n=8). Electrode configurations incorporating the middle cardiac vein (MCV) vs. Conventional non-thoracotomy lead system (RV-->AH and RV-->SCV+AH) was evaluated on Defibrillation threshold (p=<0.001). Electrode configurations incorporating the middle cardiac vein reduced mean defibrillation thresholds compared to conventional right ventricular leads.
Synapse has enriched 10 related papers. Consider them for comparative context: